Mobile

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed- Dose Study Evaluating the Effect of One Dose of Rimonabant (20 mg/day) on Glycemic Control in Type 2 Diabetic Patien...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001613-17

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed- Dose Study Evaluating the Effect of One Dose of Rimonabant (20 mg/day) on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled with Insulin

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the effect of rimonabant on HbA1c in patients with type 2 diabetes treated with insulin.

Critère d'inclusion

  • Type 2 Diabetic Patients Inadequately Controlled with Insulin

Liens